Overview

Anti-Inflammatory Agent in Sinusitis

Status:
Unknown status
Trial end date:
2020-08-01
Target enrollment:
0
Participant gender:
All
Summary
To evaluate the efficacy of an anti-inflammatory agent compared with placebo in relieving signs and symptoms of disease in patients with sinusitis.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Northwestern University
Treatments:
Anti-Inflammatory Agents
Fluticasone
Mometasone Furoate
Criteria
Inclusion Criteria:

1. Females must have a negative urine pregnancy test at screening unless documented to have
a hysterectomy or be postmenopausal.

Exclusion Criteria:

1. Inability or unwillingness of a participant to give written informed consent or comply
with study protocol

2. Use of any investigational drugs within 30 days of screening.

3. Acute infection needing antibiotic treatment at screening.